Position in ARGX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$7,277,427
+$2,361,384 QoQ
Shares Held
7,844
+16.5% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#133
of 504 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cetera Investment Advisers holds $187,106,390 across 112 Biotechnology names. ARGX ranks #6 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
78,107 | $38,798,090 | |
| 2 | IBRX |
ImmunityBio, Inc.
|
1,140,476 | $9,984,867 | |
| 3 | EXEL |
Exelixis, Inc.
|
169,657 | $9,231,037 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
14,664 | $9,143,590 | |
| 5 | OCUL |
Ocular Therapeutix, Inc
|
785,732 | $7,715,888 | |
| 6 | ARGX |
Argenx SE
This page
|
7,844 | $7,277,427 | |
| 7 | VKTX |
Viking Therapeutics, Inc.
|
184,543 | $7,199,022 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
23,196 | $6,982,691 |
All Filings in ARGX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,277,427 | 7,844 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $4,916,043 | 6,732 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $7,735,899 | 9,199 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,576,691 | 7,561 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,122,110 | 5,664 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $3,249,930 | 5,491 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $2,538,105 | 4,127 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,761,760 | 3,250 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,192,500 | 2,773 | Shares | Sole | 2024-08-22 | |
| 2024-03-31 | $1,129,582 | 2,869 | Shares | Sole | 2024-05-24 | |
| 2023-12-31 | $743,740 | 1,955 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $899,682 | 1,830 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $683,586 | 1,754 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $593,892 | 1,594 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $481,492 | 1,271 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $282,793 | 801 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $228,085 | 602 | Shares | Sole | 2022-08-11 | |
| No filing history on record for this holder in this stock. | ||||||